Jove
Visualize
Contact Us

Related Concept Videos

The Two-State Receptor Model01:29

The Two-State Receptor Model

2.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
2.4K
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

12.3K
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
12.3K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

8.0K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.0K
Tail-anchoring of Proteins in the ER Membrane01:45

Tail-anchoring of Proteins in the ER Membrane

3.2K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
3.2K
Protein Modifications in the RER01:26

Protein Modifications in the RER

5.6K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.6K
Translational Regulation01:29

Translational Regulation

98
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
98

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CDK8 inhibition induces Mediator trapping and impairment of the EWSR1::FLI1 transcriptional program in Ewing sarcoma.

Cancer discovery·2026
Same author

NLRP3 haploinsufficiency unmasks a compensatory NLRP1-NLRP3 interaction that drives accelerated aging in mice.

Science advances·2026
Same author

Effect of Pain Neuroscience Education on Pain, Sleep and Psychosocial factors in Chronic Musculoskeletal Pain Conditions: A Systematic Review and Meta-analysis.

The Clinical journal of pain·2026
Same author

Reverse-engineering amyloid strains with generative protein design.

bioRxiv : the preprint server for biology·2026
Same author

Vitiligolike Leukoderma Associated With Chronic Unilateral Topical Ophthalmic Atropine and Dorzolamide.

JAMA ophthalmology·2026
Same author

Cysteines are critical determinants of spontaneous and seeded tau aggregation in cells.

Research square·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Sep 13, 2025

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.4K

Select Azo Compounds Post-translationally Modulate HTRA1 Abundance and Activity Potentially through Interactions at

John D Hulleman1, Seungje Jeon2, Sofia Bali3,4

  • 1Department of Ophthalmology and Visual Neurosciences, University of Minnesota, 2001 Sixth St. SE, Minneapolis, Minnesota 55455, United States.

ACS Chemical Biology
|July 30, 2025
PubMed
Summary

Researchers screened 1920 compounds to find enhancers of High-temperature requirement protein A1 (HTRA1), a protein linked to age-related macular degeneration (AMD). Chicago Sky Blue 6B (CSB) increased HTRA1 levels without affecting its activity, showing potential for AMD therapeutics.

More Related Videos

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.6K
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.6K

Related Experiment Videos

Last Updated: Sep 13, 2025

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.4K
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.6K
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.6K

Area of Science:

  • Biochemistry
  • Genetics
  • Ophthalmology

Background:

  • High-temperature requirement protein A1 (HTRA1) is a serine protease implicated in neurodegenerative diseases, including age-related macular degeneration (AMD).
  • Genetic studies identify the 10q26 locus containing HTRA1 as a significant risk factor for AMD.
  • AMD-associated risk alleles in HTRA1 correlate with reduced HTRA1 synthesis in retinal pigmented epithelium (RPE), suggesting a role in disease susceptibility.

Purpose of the Study:

  • To identify small molecules that enhance HTRA1 transcription or protein abundance.
  • To develop chemical probes for investigating HTRA1 function and potential therapeutic targets for AMD.

Main Methods:

  • Utilized CRISPR/Sp.Cas9 gene editing to tag HTRA1 with a HiBiT peptide in ARPE-19 cells.
  • Screened 1920 compounds from two libraries using a high-throughput approach to identify HTRA1 enhancers.
  • Employed HiBiT blotting, genomic DNA analysis, siRNA, and serine hydrolase activity-based protein profiling (SH-ABPP) for verification and mechanistic studies.

Main Results:

  • Chicago Sky Blue 6B (CSB), an azo compound, was identified as an enhancer of HTRA1 secretion (2.0-fold) and intracellular levels (1.7-fold).
  • CSB did not alter HTRA1 transcriptional levels or its specific enzymatic activity.
  • Congo Red, a structurally similar azo compound, increased intracellular HTRA1 but impaired its enzymatic activity, suggesting differential mechanisms of action.

Conclusions:

  • Identified specific azo dyes, including CSB, as chemical probes that modulate HTRA1 levels.
  • CSB enhances HTRA1 protein abundance without affecting its catalytic function, presenting a potential starting point for HTRA1-centered therapeutics.
  • The findings provide valuable tools for further research into HTRA1's role in AMD and the development of novel therapeutic strategies.